1-4 of 4
Carlo Russo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Genetic Engineering of Hematopoietic Progenitor Stem Cells for Targeted IFN-α Immunotherapy Reprogramming the Solid Tumor Microenvironment: A First-in-Man Study in Glioblastoma Multiforme (NCT03866109)

Francesca Farina, Bernhard Gentner, Gaetano Finocchiaro, Marica Eoli, Alessia Capotondo, Elena Anghileri, Matteo Barcella, Valentina Brambilla, Matteo Giovanni Carrabba, Valeria Cuccarini, Quintino Giorgio D'Alessandris, Francesco Di Meco, Valeria Ferla, Paolo Ferroli, Filippo Gagliardi, Federico Giuseppe Legnani, Stefania Mazzoleni, Alessandro Olivi, Roberto Pallini, Massimo Saini, Karen Mullen, Luigi Naldini, Carlo Russo, Fabio Ciceri
Journal: Blood
Blood (2023) 142 (Supplement 1): 4850.
https://doi.org/10.1182/blood-2023-178212
Published: 2023
Journal Articles

Reprogramming Macrophages Using Autologous Hematopoietic Stem Cells As Immunotherapy for Glioblastoma: TEM-GBM Study (NCT03866109)

Francesca Farina, Bernhard Gentner, Gaetano Finocchiaro, Marica Eoli, Alessia Capotondo, Elena Anghileri, Matteo Barcella, Valentina Brambilla, Maria Grazie Bruzzone, Matteo Giovanni Carrabba, Valeria Cuccarini, Giorgio D'Alessandris, Francesco Di Meco, Valeria Ferla, Alberto Franzin, Paolo Ferroli, Filippo Gagliardi, Federico Legnani, Stefania Mazzoleni, Pietro Mortini, Matteo Maria Naldini, Alessandro Olivi, Roberto Pallini, Monica Patanè, Rosina Paterra, Bianca Pollo, Marco Saini, Silvia Snider, Andrew Zambanini, Luigi Naldini, Carlo Russo, Fabio Ciceri
Journal: Blood
Blood (2022) 140 (Supplement 1): 4575–4576.
https://doi.org/10.1182/blood-2022-165975
Published: 2022
Journal Articles

TEM-GBM: An Open-Label, Phase I/IIa Dose-Escalation Study Evaluating the Safety and Efficacy of Genetically Modified Tie-2 Expressing Monocytes to Deliver IFN-α within Glioblastoma Tumor Microenvironment

Bernhard Gentner, Gaetano Finocchiaro, Francesca Farina, Marica Eoli, Capotondo Alessia, Elena Anghileri, Gabriele Antonarelli, Matteo Barcella, Maria Grazia Bruzzone, Matteo Giovanni Carrabba, Valeria Cuccarini, Giorgio D'Alessandris, Francesco Di Meco, Valeria Ferla, Paolo Ferroli, Filippo Gagliardi, Mariagrazia Garramone, Federico Legnani, Pietro Mortini, Matteo Maria Naldini, Alessandro Olivi, Roberto Pallini, Monica Patanè, Rosina Paterra, Bianca Pollo, Marco Saini, Silvia Snider, Valentina Brambilla, Tiziana Magnani, Stefania Mazzoleni, Zahid Bashir, Carlo Russo, Luigi Naldini, Fabio Ciceri
Journal: Blood
Blood (2021) 138 (Supplement 1): 2844.
https://doi.org/10.1182/blood-2021-150230
Published: 2021
Journal Articles

TEM-MM-101: A Phase I/IIa Dose Escalation Study Evaluating the Safety and Activity of Autologous CD34+ Enriched Hematopoietic Progenitor Cells Genetically Modified for Human Interferon-α2 in Multiple Myeloma Patients with Early Relapse after Intensive Front Line Therapy

Bernhard Gentner, MD, Francesca Farina, MD, Matteo Giovanni Carrabba, MD, Magda Marcatti, MD, Stefania Girlanda, MD, Gabriele Antonarelli, MD, Capotondo Alessia, PhD, Stefania Mazzoleni, PhD, Carlo Russo, MD, Luigi Naldini, MD PhD, Fabio Ciceri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2064.
https://doi.org/10.1182/blood-2019-123749
Published: 2019